How much funding has Cytek Biosciences raised?

Cytek Biosciences has raised $24.3M in total funding, most recently a series c round.

Who are Cytek Biosciences's investors?

Cytek Biosciences's investors include Easy Prosperity, F-Prime Capital, Eight Roads Ventures, Northern Light Venture Capital, RA Capital Management, 3E Bioventures Capital.

Where is Cytek Biosciences headquartered?

Cytek Biosciences is headquartered in United States.

What industry is Cytek Biosciences in?

Cytek Biosciences operates in Biotech, Manufacturing.

Cytek Biosciences

IPO

Public · United States · $24.3M raised

Biotech

Manufacturing

Business Model: B2B
Total Funding: $24.3M
Last Round: $12.0M Series CSep 2018

Rounds: 3
Type: Public

About

Cytek Biosciences designs and manufactures full spectrum flow cytometry systems for research and clinical applications.

Summary

Cytek Biosciences is a Biotech company based in United States. It has raised $24.3M in total across 3 rounds, most recently a $12.0M Series C round in Sep 2018. Investors include Easy Prosperity, F-Prime Capital and Eight Roads Ventures.